Improving the in vitro and in vivo performance of a 177Lu-labeled phosphoramidate-based PSMA inhibitor with an albumin-binding motif

被引：0
|
作者：
Choy, Cindy [1 ]
Ling, Xiaoxi [2 ]
Geruntho, Jonathan [2 ]
Beyers, Sophia [1 ]
Latoche, Joseph [2 ]
Langton-Webster, Beatrice [1 ]
Anderson, Carolyn [2 ]
Berkman, Clifford [1 ]
机构：
[1] Canc Targeted Technol, Woodinville, WA USA
[2] Univ Pittsburgh, Radiol, Pittsburgh, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 253卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
275
引用
收藏
页数：1
相关论文
共 39 条
  • [21] In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues
    Regi Thomas
    Jianqing Chen
    Martine M. Roudier
    Robert L. Vessella
    Laura E. Lantry
    Adrian D. Nunn
    Clinical & Experimental Metastasis, 2009, 26
  • [22] Characterization of a 177Lu-labeled albumin binding CXCR4-targeting peptide in a neuroendocrine prostate cancer model
    Astiazaran, Itzel
    Kuo, Hsiou-Ting
    Kurkowska, Sara
    Merkens, Helen
    Colpo, Nadine
    Ng, Pauline
    Ong, Christopher
    Wang, Yuzhuo
    Lin, Kuo-Shyan
    Benard, Francois
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [23] Influence of chelator type on in vitro receptor binding and stability in 177Lu-labeled anti-EGFR monoclonal antibodies
    Novy, Z.
    Laznickova, A.
    Mandikova, J.
    Laznicek, M.
    Trejtnar, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S429 - S429
  • [24] Investigation of 68Ga/177Lu-labeled FAP-based inhibitor for diagnostic and therapeutic applications
    Imlimthan, Surachet
    Menendez, Elena
    Escudero-Castellanos, Alondra
    Moon, Euy Sung
    Laeppchen, Tilman
    Rathke, Hendrik
    Afshar-Oromieh, Ali
    Roesch, Frank
    Rominger, Axel
    Gourni, Eleni
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S56 - S57
  • [25] A 177Lu-labeled albumin-binder-conjugated PSMA-617 derivative with greatly enhanced radiation dose delivered to LNCaP tumor xenografts
    Kuo, Hsiou-Ting
    Merkens, Helen
    Zhang, Zhengxing
    Uribe, Carlos
    Zhang, Chengcheng
    Lau, Joseph
    Colpo, Nadine
    Benard, Francois
    Lin, Kuo-Shyan
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [26] Clinical translation of the albumin-binding radioligand 177Lu-(S)-Ibu-DAB-PSMA in patients with mCRPC: Enhancing clinical efficacy of PSMA-targeted RLT
    Fernandez, R.
    Nicolai, H.
    Ritt, P.
    Soza-Ried, C.
    Rogers, A.
    Qin, Y.
    Meckel, M.
    Fliegert, F.
    Ceballos, M.
    Wettlin, J.
    Amaral, H.
    Zhernosekov, K.
    Borgna, F.
    Deberle, L. M.
    Schibli, R.
    Mueller, C.
    Martinez, C.
    Del Castillo, C.
    Kramer, V
    EUROPEAN UROLOGY, 2024, 85 : S1441 - S1441
  • [27] Investigation of the Effect on the Albumin Binding Moiety for the Pharmacokinetic Properties of 68Ga-, 205/206Bi-, and 177Lu-Labeled NAPamide-Based Radiopharmaceuticals
    Szucs, Daniel
    Szabo, Judit P.
    Arato, Viktoria
    Gyuricza, Barbara
    Szikra, Dezso
    Toth, Imre
    Kepes, Zita
    Trencsenyi, Gyorgy
    Fekete, Aniko
    PHARMACEUTICALS, 2023, 16 (09)
  • [28] 177Lu-labeled Lys-urea-Aad-based PSMA-targeting radiotherapeutic agents with low uptake in mouse kidneys and salivary glands
    Kuo, Hsiou-Ting
    Zhang, Zhengxing
    Merkens, Helen
    Zhang, Chengcheng
    Lin, Kuo-Shyan
    Benard, Francois
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S32 - S33
  • [29] Novel 177Lu-labeled albumin-binder-conjugated PSMA-targeting agents with extremely high tumor uptake and superior tumor-to-kidney therapeutic index
    Kuo, H.
    Zhang, Z.
    Uribe, C.
    Merkens, H.
    Zhang, C.
    Benard, F.
    Lin, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S13 - S14
  • [30] 177Lu-Labeled Albumin-Binder-Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
    Kuo, Hsiou-Ting
    Lin, Kuo-Shyan
    Zhang, Zhengxing
    Uribe, Carlos F.
    Merkens, Helen
    Zhang, Chengcheng
    Benard, Francois
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (04) : 521 - 527
1234